Back to TD Waterhouse Canada Inc. TD Waterhouse Canada Inc.

EPRXEPRX
8 quarters

Position history for TD Waterhouse Canada Inc.TD Waterhouse Canada Inc.'s holdings in EUPRAXIA PHARMACEUTICALS INC

TD Waterhouse Canada Inc. holds 79,607 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $534,915 as of 2026-Q2. The position was decreased (-2.6% shares). EPRX represents 0.0% of TD Waterhouse Canada Inc.'s portfolio.

Current Value

$534,915

Current Shares

79,607

Total Value Change

+$531,080

Total Shares Change

+78,107

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
79,607
-2.6%
$534,9150.0%$6.61
0
2026-Q1
Increased
81,725
+751.3%
$589,8040.0%$8.02
39
2025-Q4
Unchanged
9,600
0.0%
$71,6940.0%$7.59
0
2025-Q3
Unchanged
9,600
0.0%
$56,2270.0%$5.75
0
2025-Q2
Decreased
9,600
-90.9%
$55,8860.0%$5.30
0
2025-Q1
New
104,986
-
$343,2590.0%$3.38
33
2024-Q4
Exited
0
-100.0%
$00.0%$3.09
0
2024-Q3
New
1,500
-
$3,8350.0%$2.63
22

Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used